4//SEC Filing
Prokocimer Philippe 4
Accession 0001181431-12-019759
CIK 0001356857other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:57 PM ET
Size
7.3 KB
Accession
0001181431-12-019759
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2012-03-23−6,244→ 0 totalExercise: $0.52Exp: 2018-01-09→ Common Stock (6,244 underlying) - Exercise/Conversion
Common Stock
2012-03-23$0.52/sh+6,244$3,247→ 98,022 total(indirect: By Trust)
Holdings
- 9,499
Common Stock
Footnotes (1)
- [F1]25% of the shares subject to the 14,244 share option grant vested on 1/1/09, with the remainder vesting monthly thereafter until fully vested on 1/1/12.
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeother
Related Parties
1- filerCIK 0001479790
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:57 PM ET
- Size
- 7.3 KB